Phthalates in Perfume: What Pregnant Women Should Know

Aimée's Journal•
A clear glass perfume bottle catching soft natural light

Most pregnancy advice on perfume is either fear-based or marketing-spun. Phthalates, synthetic musks, and the regulations that actually matter — explained.

Phthalates in perfume — the plasticizers used to make conventional fragrance linger on skin — appear on the European Chemicals Agency's Substances of Very High Concern Candidate List, with five ortho-phthalates (DEHP, DBP, DIBP, BBP and DCHP) flagged for endocrine-disrupting properties affecting human health (ECHA, 2024). Yet the question pregnant women are usually given is a binary one: is perfume safe during pregnancy, or isn't it. The honest answer lives in the middle. Which compounds, and which trimester, are the only questions worth asking.

An endocrine-disrupting chemical (EDC) is, in the working definition adopted by the European Commission and the World Health Organization, an exogenous substance or mixture that alters the function of the endocrine system and consequently causes adverse health effects in an intact organism, its progeny, or sub-populations. That definition is what regulators reach for when they decide whether endocrine disruptors in fragrance belong on a restriction list. The European Chemicals Agency operates two such lists. The Candidate List of Substances of Very High Concern flags chemicals deserving regulatory attention. The Authorisation List (Annex XIV of REACH) makes their use conditional on an explicit licence. A growing share of the perfume industry's mid-twentieth-century chemistry now sits on one or both.

Phthalates in perfume: the regulatory landscape

Phthalates are a family of esters used in fragrance to dissolve aroma molecules and slow their evaporation. Three matter for perfumery: DEHP (di(2-ethylhexyl) phthalate), DBP (dibutyl phthalate) and DEP (diethyl phthalate). The first two are essentially gone from European cosmetics. The third is not.

Under EU Cosmetic Regulation (EC) No 1223/2009, DEHP, DBP, BBP and DIBP are restricted as a group in consumer products to a maximum of 0.1% by weight. ECHA added endocrine-disrupting properties to the Authorisation List entries for these four phthalates, formalising what reproductive toxicologists had argued for a decade (ECHA, 2023). For European cosmetic formulators, the practical effect is that DEHP and DBP are excluded from finished perfume.

DEP is the awkward one. The U.S. Food and Drug Administration's current position on phthalates in cosmetics (FDA, 2022) is that it has no safety concerns with DEP as currently used — a stance unchanged through 2024. The Cosmetic Ingredient Review Expert Panel reopened its DEP assessment in 2024 specifically because of new reproductive, developmental and endocrine data; industry surveys show DEP appearing in roughly 168 U.S. fragrance formulations at concentrations up to 0.15%. Health Canada's Cosmetic Ingredient Hotlist (Health Canada, 2024), last revised in May 2024 and updated again in August 2025, restricts several phthalates but does not prohibit DEP outright. The result: a perfume sold legally in Toronto or Chicago can contain DEP that the same brand removes for the Paris shelf.

What the recent epidemiology actually shows

The 2023–2025 evidence on prenatal phthalate exposure is unusually consistent for an environmental-health field. A pooled analysis of 5,006 mother-child dyads across 13 U.S. cohorts in the National Institutes of Health ECHO program reported that prenatal exposure to DEHP was associated with preterm birth at an odds ratio of 1.45, with even larger effects for phthalic acid, DiNP, DiDP and DnOP — and an estimated 56,595 phthalate-attributable preterm births in the United States in 2018 alone, with associated costs of US$3.84 billion (The Lancet Planetary Health, 2024).

Subsequent prospective work has linked maternal phthalate exposure to altered thyroid hormone profiles in pregnancy (PubMed, 2024) and to changes in chorionic plate vasculature at delivery (PMC, 2025). A 2025 systematic review in Frontiers in Endocrinology documents the association between phthalate exposure and gestational diabetes (Frontiers in Endocrinology, 2025). None of these papers say perfume alone causes preterm birth. They say cumulative phthalate exposure during gestation is a measurable, modifiable contributor — and fragrance is one of the larger discretionary sources.

The synthetic-musk question

Two polycyclic synthetic musks dominate mass-market fragrance: galaxolide (HHCB, registered as 1,3,4,6,7,8-hexahydro-4,6,6,7,8,8-hexamethylcyclopenta-γ-2-benzopyran) and tonalide (AHTN). They are cheap, stable, and lack the metabolic handles that allow biodegradation. They also lack the metabolic handles that would let a human body clear them.

Both compounds have been measured in human breast milk, adipose tissue, blood and umbilical cord blood (Environmental Health Perspectives / PMC). Reported breast-milk concentrations span 0.44 µg per gram of lipid in earlier surveys to ranges of 58–108 µg/L in more recent work. In vitro, both compounds compromise the efflux transporters that cells use to expel xenobiotics, with effects persisting 48 hours after exposure ends. Long-term sub-lethal exposure to HHCB and AHTN has been shown to promote metastatic potential in glioblastoma tumour spheroids (NeuroToxicology, 2021).

Synthetic musks do not appear on the ECHA SVHC list. They are not banned in any major jurisdiction. They are also bioaccumulative, persistent and present in the bodies of newborns who have not yet smelled a perfume. A reasonable pregnant consumer can read those two facts and conclude that the precautionary action is not waiting for the regulatory list to catch up. Industry has begun, quietly, to move — the International Fragrance Association tightened its HHCB usage standard in 2020, and several European houses have replaced polycyclic musks with macrocyclic alternatives that biodegrade. Most North American mass-market fragrance has not. INCI declarations remain optional for individual fragrance components on this side of the Atlantic, which is exactly why the line of evidence and the line of regulation diverge in retail.

Natural is not a synonym for safe

The countervailing wellness narrative — that any “natural” fragrance is automatically pregnancy-appropriate — falls apart on contact with aromatherapy literature. Several botanical materials common in artisanal perfume carry pregnancy contraindications well-documented in clinical aromatherapy reviews and obstetric guidance (PMC, 2021).

  • Sage (Salvia officinalis) — thujone content; uterine stimulant; avoided across all trimesters.
  • Rosemary CT camphor (Rosmarinus officinalis) — camphor crosses the placenta and is neurotoxic at high oral doses; topical fragrance use is lower-risk but still avoided in the first trimester.
  • Basil (Ocimum basilicum, methyl-chavicol type) — methyl chavicol concerns; avoided.
  • Pennyroyal, wintergreen, hyssop, parsley seed, tansy — uterine stimulants or hepatotoxic; never used in pregnancy-safe formulation.

A natural perfumer working seriously with pregnancy excludes these materials by name — not because every drop is dangerous on skin, but because the discipline of restricting upstream is the only honest version of “pregnancy safe.”

Is perfume safe during pregnancy? A trimester-by-trimester answer

The first trimester is when organogenesis happens and when miscarriage risk is highest, so the bar for any non-essential exposure is highest. Reviews and obstetric guidance converge on a conservative position: avoid known uterine-stimulant essential oils, avoid undocumented synthetic fragrance entirely, and where fragrance is used, prefer formulations whose full INCI is disclosed and whose phthalate and synthetic-musk status is verifiable. The data does not support “all perfume must be stopped.” It supports replacing unknown formulations with known ones.

A practical trimester reference

Trimester Generally avoided Generally tolerated (in pregnancy-safe formulation)
First (weeks 1–13) All sage, rosemary CT camphor, basil, pennyroyal, wintergreen, hyssop, clary sage; any perfume with undisclosed synthetic musks or DEP Hydrosols (rose, neroli, orange blossom); citrus zest essences at low dilution; documented natural perfumes formulated for pregnancy
Second (weeks 14–27) Same uterine-stimulant essential oils; phthalate-containing fragrance Wider palette of florals and citrus in finished perfume; light woods (cedar, sandalwood) within COSMOS Natural framework
Third (weeks 28–40) Strong stimulants until term; clary sage saved for active labour under qualified care Documented pregnancy-safe perfumes; calming florals; chamomile, lavender (true) at low dilution

This table summarises consensus in clinical aromatherapy reviews and is not medical advice. Anyone with a high-risk pregnancy, history of pregnancy loss, or hyperemesis should consult an obstetrician before any aromatic exposure.

How to read a perfume INCI as a pregnant consumer

Three habits do most of the work.

  1. Look for an actual ingredient list. EU and Canadian law require it; if a perfume sold in North America hides behind “Fragrance (Parfum)” with no further detail, you cannot evaluate it. That is the first yellow flag.
  2. Search for “phthalate” and the strings “DEP”, “diethyl phthalate”, “HHCB”, “galaxolide”, “AHTN”, “tonalide”. Their absence on the label is not proof of absence in the bottle — but their presence is conclusive.
  3. Check for the COSMOS Natural seal or an equivalent third-party standard. Self-declared “clean” means nothing in regulatory terms. COSMOS Natural certification excludes the compound classes that matter here.

Aimée de Mars, formulating in Mévouillon under COSMOS Natural certification, builds without phthalates, synthetic musks, parabens, or ethanol of undocumented origin — the same standard that quietly disqualifies most of what is sold as “French perfume” in North America.

Where to go from here

The shortest route from this article to a wearable answer is the pregnancy-safe collection, where every formulation has been screened against the criteria above. For the longer reference — trimester-by-trimester safe-ingredient inventory, what to ask a perfumer, how COSMOS certification interacts with EU and Health Canada lists — see the pregnancy fragrance guide. If breastfeeding is the next chapter, the companion piece on nursing and perfume picks up where this one ends.

Sources

clean-fragrance pregnancy
Share

Related Articles